These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

455 related articles for article (PubMed ID: 28717651)

  • 21. Long-Term Outcome of Prostatic Artery Embolization for Patients with Benign Prostatic Hyperplasia: Single-Centre Retrospective Study in 1072 Patients Over a 10-Year Period.
    Bilhim T; Costa NV; Torres D; Pinheiro LC; Spaepen E
    Cardiovasc Intervent Radiol; 2022 Sep; 45(9):1324-1336. PubMed ID: 35778579
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prostate artery embolization has long term efficacy for treatment of severe lower urinary tract symptoms from giant prostatic hyperplasia.
    Somwaru AS; Metting S; Flisnik LM; Nellamattathil MG; Sharma A; Katabathina VS
    BMC Urol; 2020 Oct; 20(1):153. PubMed ID: 33032577
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prostatic artery embolization in benign prostatic hyperplasia: preliminary results in 13 patients.
    Grosso M; Balderi A; Arnò M; Sortino D; Antonietti A; Pedrazzini F; Giovinazzo G; Vinay C; Maugeri O; Ambruosi C; Arena G
    Radiol Med; 2015 Apr; 120(4):361-8. PubMed ID: 25245496
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prostatic artery embolization for the treatment of symptomatic benign prostatic hyperplasia in men ≥75 years: a prospective single-center study.
    Wang MQ; Wang Y; Yan JY; Yuan K; Zhang GD; Duan F; Li K
    World J Urol; 2016 Sep; 34(9):1275-83. PubMed ID: 26818021
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intra-vesical Prostatic Protrusion (IPP) Can Be Reduced by Prostatic Artery Embolization.
    Lin YT; Amouyal G; Thiounn N; Pellerin O; Pereira H; Del Giudice C; Déan C; Sapoval M
    Cardiovasc Intervent Radiol; 2016 May; 39(5):690-695. PubMed ID: 26542027
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prostatic Artery Embolization with 250-μm Spherical Polyzene-Coated Hydrogel Microspheres for Lower Urinary Tract Symptoms with Follow-up MR Imaging.
    Franiel T; Aschenbach R; Trupp S; Lehmann T; von Rundstedt FC; Grimm MO; Teichgräber U
    J Vasc Interv Radiol; 2018 Aug; 29(8):1127-1137. PubMed ID: 29910163
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prostate artery embolisation: an all-comers, single-operator experience in 159 patients with lower urinary tract symptoms, urinary retention, or haematuria with medium-term follow-up.
    Thulasidasan N; Kok HK; Elhage O; Clovis S; Popert R; Sabharwal T
    Clin Radiol; 2019 Jul; 74(7):569.e1-569.e8. PubMed ID: 30955835
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of Prostatic Artery Embolization on the Dynamic Component of Benign Prostate Hyperplasia as Assessed by Ultrasound Elastography: A Pilot Series.
    de Assis AM; Moreira AM; Carnevale FC; Marcelino ASZ; de Oliveira Cerri LM; Antunes AA; Srougi M; Cerri GG
    Cardiovasc Intervent Radiol; 2019 Jul; 42(7):1001-1007. PubMed ID: 30993369
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Safety and Efficacy of Occlusion of Large Extra-Prostatic Anastomoses During Prostatic Artery Embolization for Symptomatic BPH.
    Amouyal G; Chague P; Pellerin O; Pereira H; Del Giudice C; Dean C; Thiounn N; Sapoval M
    Cardiovasc Intervent Radiol; 2016 Sep; 39(9):1245-55. PubMed ID: 27412754
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prostatic Tissue Elimination After Prostatic Artery Embolization (PAE): A Report of Three Cases.
    Leite LC; de Assis AM; Moreira AM; Harward SH; Antunes AA; Carnevale FC
    Cardiovasc Intervent Radiol; 2017 Jun; 40(6):937-941. PubMed ID: 28175975
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparing embolic particles for prostatic artery embolization to treat lower urinary tract symptoms in patients with benign prostatic hyperplasia.
    Bilhim T; Vasco Costa N; Torres D; Akış S; Alves M; Papoila AL
    Eur Radiol; 2024 Aug; ():. PubMed ID: 39107451
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Embolisation of prostatic arteries as treatment of moderate to severe lower urinary symptoms (LUTS) secondary to benign hyperplasia: results of short- and mid-term follow-up.
    Pisco JM; Rio Tinto H; Campos Pinheiro L; Bilhim T; Duarte M; Fernandes L; Pereira J; Oliveira AG
    Eur Radiol; 2013 Sep; 23(9):2561-72. PubMed ID: 23370938
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Randomised Clinical Trial of Prostatic Artery Embolisation Versus a Sham Procedure for Benign Prostatic Hyperplasia.
    Pisco JM; Bilhim T; Costa NV; Torres D; Pisco J; Pinheiro LC; Oliveira AG
    Eur Urol; 2020 Mar; 77(3):354-362. PubMed ID: 31831295
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prostatic Artery Embolization (PAE) Using Polyethylene Glycol Microspheres: Safety and Efficacy in 81 Patients.
    Insausti I; Galbete A; Lucas-Cava V; de Ocáriz AS; Solchaga S; Monreal R; de la Cuesta AM; Alfaro R; Sun F; Montesino M; Urtasun F; Bilbao Jaureguízar JI
    Cardiovasc Intervent Radiol; 2022 Sep; 45(9):1339-1348. PubMed ID: 35655035
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Case-Control Comparison of Conventional End-Hole versus Balloon-Occlusion Microcatheter Prostatic Artery Embolization for Treatment of Symptomatic Benign Prostatic Hyperplasia.
    Ayyagari R; Powell T; Staib L; Chapiro J; Schoenberger S; Devito R; Pollak J
    J Vasc Interv Radiol; 2019 Sep; 30(9):1459-1470. PubMed ID: 31375451
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prostatic Artery Embolization (PAE) for Benign Prostatic Hyperplasia (BPH) with Haematuria in the Absence of an Upper Urinary Tract Pathology.
    Tapping CR; Macdonald A; Hadi M; Mortensen C; Crew J; Protheroe A; Little MW; Boardman P
    Cardiovasc Intervent Radiol; 2018 Aug; 41(8):1160-1164. PubMed ID: 29582127
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy and safety of prostate artery embolization on lower urinary tract symptoms related to benign prostatic hyperplasia: a systematic review and meta-analysis.
    Wang XY; Zong HT; Zhang Y
    Clin Interv Aging; 2016; 11():1609-1622. PubMed ID: 27956827
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of 5-Alpha-Reductase Inhibitors Use at the Time of Prostatic Artery Embolization for Treatment of Benign Prostatic Obstruction.
    Cardarelli-Leite L; de Assis AM; Moreira AM; Antunes AA; Cerri GG; Srougi M; Carnevale FC
    J Vasc Interv Radiol; 2019 Feb; 30(2):228-232. PubMed ID: 30717954
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prostatic artery embolization in treating benign prostatic hyperplasia: a systematic review.
    Teoh JY; Chiu PK; Yee CH; Wong HM; Chan CK; Chan ES; Hou SS; Ng CF
    Int Urol Nephrol; 2017 Feb; 49(2):197-203. PubMed ID: 27896579
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Early results from a United States trial of prostatic artery embolization in the treatment of benign prostatic hyperplasia.
    Bagla S; Martin CP; van Breda A; Sheridan MJ; Sterling KM; Papadouris D; Rholl KS; Smirniotopoulos JB; van Breda A
    J Vasc Interv Radiol; 2014 Jan; 25(1):47-52. PubMed ID: 24176946
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.